Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107353245B reveals metal-free photocatalytic route. Delivers high purity quinoline intermediates with significant supply chain and cost advantages for global buyers.
Patent CN109912487B reveals a novel non-transition metal catalytic route for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages.
Novel visible-light mediated method for 1,1-diarylalkanes. High yield, mild conditions. Ideal for pharmaceutical intermediate manufacturing and supply chain optimization.
Novel bimetallic catalyst method for high-purity N,N-dialkyl unsaturated acyl amine manufacturing with significant cost reduction and supply chain reliability.
Patent CN106676573A reveals green electrochemical route for aromatic nitriles. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN117700410B reveals a high-yield synthesis for Paliperidone intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114920648B reveals ionic liquid catalyst for MDJ intermediate. Solvent-free process ensures high purity and supply chain stability for global fragrance manufacturers.
Patent CN114920648B reveals solvent-free ionic liquid catalysis for MDJ intermediates, offering substantial cost reduction and enhanced supply chain reliability for global manufacturers.
Patent CN101066924B reveals a streamlined chemical synthesis for Orlistat intermediates, offering high purity and scalable production for pharmaceutical manufacturers.
Patent CN114920648B reveals ionic liquid catalyst for MDJ intermediate. Solvent-free process ensures supply chain stability and cost efficiency.
Novel synthesis method for Paxlovid intermediate offering high purity and scalable production capabilities for global pharmaceutical supply chains and significant cost efficiency.
Novel catalytic route for (S)-Oxiracetam ensures 99.8% purity and 80% yield. Cost-effective scalable manufacturing for pharmaceutical supply chains.
Advanced biocatalytic synthesis of betulinic acid using ionic liquids. Enhances yield and supply chain reliability for pharmaceutical intermediates.
Patent CN102226213B details enzymatic betulinic acid production. Offers safe, scalable pharmaceutical intermediate manufacturing with reduced environmental impact.
Patent CN102617259A reveals a solvent-free, non-transition metal catalytic method for amine synthesis. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN102250076A reveals a mild, high-yield route for Rivaroxaban intermediates using magnesium halides, offering significant cost reduction and supply chain reliability for API manufacturers.
Metal-free Brønsted acid catalyzed synthesis of trans-3,4-diaryl dihydrocoumarins with high diastereoselectivity. Ideal for scalable API intermediate manufacturing.
Patent CN109180592B details a green synthesis of 7-chloro-2-(3-chlorophenyl)quinazoline using NNN-Ru catalysts. Discover cost-effective, scalable manufacturing solutions.
Patent CN114478608A discloses Rh-catalyzed enantioselective silylation. Offers high ee values and novel structures for functional materials and pharma intermediates.
Patent CN109232176A reveals mild room temperature bromination. Offers high purity intermediates for pharma supply chains with reduced metal contamination risks.